Stories

The financial results for the first half of the year will be published on July 25, 2024 at 7H00 and a conference call will take place at 13H00 CET.

The ESG Life Sciences Summit Europe, held in June brought together industry leaders to discuss how the life sciences sector can drive meaningful change through ESG initiatives. 

When Eric Gratton joined Ipsen from a large financial services firm, he was surprised to find there wasn’t an employee resource group (ERG) dedicated to the LGBTQIA+ community. “Being the over-achiever I am, I thought I should start one: a little passion project for the community and its allies.”

At the European Association for the Study of the Liver (EASL) congress, leading liver experts discuss the importance of proactive, personalized care and shared decision-making during consultations. A personalized care approach begins by listening to the patient’s feelings and needs, which can result

In 2023, we entered the next phase of our journey of growth and innovation, reinforcing our position as a leading mid-sized biopharmaceutical company. With a sharp focus on our three therapy areas of Oncology, Rare Diseases, and Neuroscience, we achieved total sales of €3,128 m.